Le Lézard
Classified in: Health, Science and technology, Covid-19 virus

World Pharmacovigilance Market Size, Share & Trends, Analysis & Forecast Report 2022-2030: Increasing Externalization of Clinical Trial Studies by Large Pharmaceutical and Biopharmaceutical Companies - ResearchAndMarkets.com


The "Pharmacovigilance Market Size, Share & Trends Analysis Report by Product Life Cycle, by Service Provider, by Type, by Process Flow, by Therapeutic Area, by End-use, by Region, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.

The global pharmacovigilance market size is expected to reach USD 17.36 billion by 2030 and is expected to expand at a CAGR of 10.5% from 2022 to 2030.

Increasing incidence of Adverse Drug Reactions (ADRs) is the key growth driver. ADR imposes a substantial burden on healthcare systems and is one of the prominent causes of morbidity in developed countries. According to the National Center for Biotechnology Information (NCBI), approximately 5% of total hospitalizations in Europe each year are due to ADR. Pharmacovigilance services play an integral role in this clinical trial phase by assisting manufacturers in identifying adverse effects associated with the drug.

COVID-19 has undoubtedly thrown up numerous challenges as well as opportunities for pharmacovigilance service providers. Various companies are developing innovative platforms to gain a competitive edge. For instance, in December 2020, ArisGlobal and EVERSANA declared a strategic partnership to digitally transform end-to-end pharmacovigilance services globally.

The community involved in a PV procedure has been quick to respond to the pandemic. Some companies are using big data analytics against COVID-19. Thus, this refers to the in-depth analysis of data from multiple sources. In April 2020, Saama Technologies offered its Life Science Analytics Cloud technology platform to support the consortium creation. The purpose is to fetch data from both current and future studies to slash the time required to discover a treatment by as much as 50%. Life Science Analytics Cloud is an artificial intelligence-powered platform. This represents the scope for future developments in this market.

According to the World Health Organization's (WHO) report on pharmaceutical consumption, chronic disease medications accounted for the larger proportion of the total volume of drug consumption in non-hospital setups. Hence, there has been a significant rise in the number of medicines made available to healthcare consumers. The rising demand for drugs has significantly heightened the need for the development of novel therapeutics via extensive clinical trials, which is expected to serve this market with lucrative opportunities.

Moreover, leading pharma companies in developed countries are focusing on outsourcing PV services to reduce costs and minimize operational expenses. This is anticipated to serve as an opportunity for contact research organizations in developing regions to gain more revenue share. Manufacturers are now focusing on remodeling their product development processes in an attempt to cater to patient needs across the globe. These factors are anticipated to fuel the demand for pharmacovigilance services during the forecast period.

The companies operating in the market are undertaking strategic initiatives, such as collaborations with the PV service providers, to gain access to medical information and to manage PV workflows. For instance, In October 2021, The Whiteboard, an academy for training specialists in the clinical trials and drug development field, proclaimed a partnership with Oviya MedSafe, a worldwide drug safety service, and pharmacovigilance consulting corporation.

Similarly, in September 2019, Accenture collaborated with Bayer to implement the company's INTIENT Clinical platform to simplify and speed its drug development processes, thereby widening its business. The company collaborated with BioCelebrate in the past to develop a platform for aggregating and analyzing clinical information for improved drug developing efficiency, thus enhancing its R&D capabilities. Such initiatives help companies maintain their position and thereby support market growth.

Pharmacovigilance Market Report Highlights

Pharmacovigilance Market Dynamics

Market driver analysis

Market restraint analysis

Industry Challenges

Pharmacovigilance Market Analysis Tools: Porters

SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)

Value Chain Analysis

Mapping of Life Cycle Against Service Offering And Their Demand

Regulatory Framework

Pharmacovigilance: Organization Structure Introduction

Pricing Models

Technology Timeline Overview

COVID-19 Impact Analysis

COVID-19 Outbreak

Demand Analysis

Recent Developments & Strategic Outcomes

Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/5u8auc


These press releases may also interest you

at 05:42
Trina Solar has once again been placed as a "Top Performer" 2022 among global PV module manufacturers by PV Evolution Labs (PVEL), a world-renowned third-party reliability testing laboratory, after months of rigorous testing. This is the eighth...

at 05:40
Xago Technologies (Pty) Ltd. in CAPE TOWN, South Africa, announces the launch of Xago XUS which supports the US dollar, empowering clients to deposit and payout funds, with US dollars and USDC via the Xago platform. Founded in 2016, Xago enables...

at 05:35
Atom Bioscience (Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.), a clinical stage biotechnology company developing new treatments for metabolic and inflammatory diseases, such as gout, is marking Gout Awareness Day, May 22, 2022, by drawing...

at 05:30
In the latest study, Fact.MR provides an in-depth analysis on the global train control and management systems market from 2022 to 2031. The survey also uncovers key factors such as recent developments, opportunities, drivers influencing the growth in...

at 05:30
The Insight Partners published latest research study on "Conductive Inks Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Silver Conductive Ink, Carbon Conductive Ink, Polymer Conductive Ink, Copper Conductive Ink, and Others)...

at 05:26
The 15th Session of the Conference of the Parties (COP15) of the United Nations Convention to Combat Desertification (UNCCD) kicked off on May 9, 2022 in Abidjan, Côte d'Ivoire. The UNCCD COP15 brings together leaders from governments, the private...



News published on 21 january 2022 at 09:10 and distributed by: